REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY-Reference-Cited by-同舟云学术

REDUCED VASCULAR DENSITY IN THE CHOROID AFTER TREATMENT WITH PHOTODYNAMIC THERAPY COMBINED WITH AFLIBERCEPT IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY

Published:2020-04-02 Issue:1 Volume:41 Page:156-161
ISSN:0275-004X
Container-title:Retina
language:en
Short-container-title:

Author:

Mukai Ryo,Matsumoto Hidetaka,Miyakubo Tomoko,Akiyama Hideo

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Ophthalmology,General Medicine

Reference21 articles.

1. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials—TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group;Arch Ophthalmol,1999

2. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial—VIP report no. 3;Blinder;Ophthalmology,2003

3. Ranibizumab for neovascular age-related macular degeneration;Rosenfeld;N Engl J Med,2006

4. Ranibizumab versus verteporfin for neovascular age-related macular degeneration;Brown;N Engl J Med,2006

5. One-year results of intravitreal aflibercept for polypoidal choroidal vasculopathy;Yamamoto;Ophthalmology,2015

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship between pulsation of posterior vortex vein, choroidal thickness, and choroidal vascular hyperpermeability in polypoidal choroidal vasculopathy;Graefe's Archive for Clinical and Experimental Ophthalmology;2023-08-24

2. Occlusion of a Vortex Vein After Treatment With Half-Fluence Photodynamic Therapy Combined With Intravitreal Aflibercept Injection for Pachychoroid Neovasculopathy;Cureus;2022-08-04

3. Choroidal Volume Evaluation after Photodynamic Therapy Using New Optical Coherence Tomography Imaging Algorithm;Pharmaceuticals;2021-11-10